Sign In
Buy LLY
$1,131.42
+6.04 (+0.537%)
At Close: Jun 05, 2026
Eli Lilly: A Rare Buying Opportunity
06:20am, Tuesday, 17'th Dec 2024
Eli Lilly's robust product portfolio, strategic acquisitions, and innovation-led initiatives drive its strong growth, positioning it well in the weight-loss, immunology, and oncology markets. LLY's ke
Lilly and EVA Pharma announce regulatory approval and release of locally manufactured insulin in Egypt
06:00am, Tuesday, 17'th Dec 2024
This milestone stems from the companies' collaboration to expand access to affordable insulin to one million people living with diabetes in low- to middle-income c ountries annually by 2030 INDIANAPOL
EMA Panel Endorses Lilly's Omvoh for Expanded Use in Crohn's Disease
08:26am, Monday, 16'th Dec 2024
The CHMP's opinion is based on late-stage data, which show that LLY's Omvoh is effective in Crohn's disease patients with or without prior biologic failure.
SAN FRANCISCO and SUZHOU, China, Dec. 15, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commerciali
2 Brand-New Reasons to Buy Eli Lilly Stock Right Now, and 2 Reasons to Be Cautious
02:05pm, Sunday, 15'th Dec 2024
As a major pharmaceutical company that is constantly innovating and developing new treatments, Eli Lilly (LLY 0.86%) is always providing investors with additional reasons to consider buying its stock.
Did Eli Lilly Just Say "Checkmate" to Novo Nordisk?
08:17am, Sunday, 15'th Dec 2024
Eli Lilly (LLY 0.86%) and Novo Nordisk (NVO -1.53%) have competed for decades. They're both leaders in the areas of insulin and broader diabetes drugs, where they've made significant breakthroughs and
2 Weight Loss Stocks That Are Screaming Buys in December
06:40am, Sunday, 15'th Dec 2024
With drugs like Novo Nordisk's Wegovy becoming household names over the last couple of years, it's no surprise that there are quite a few opportunities to invest in the burgeoning market for weight-lo
3 Unstoppable Stocks to Buy Right Now
06:07am, Sunday, 15'th Dec 2024
Some stocks sizzle, then fizzle. Others, though, build long-lasting momentum thanks to strong underlying business fundamentals.
Novo Nordisk's CagriSema May Trump Lilly's Zepbound - Buy This Dip
02:00pm, Friday, 13'th Dec 2024
NVO's reiterated FY2024 guidance and underwhelming FY2025 guidance in "the high teens" imply growth headwinds after the high-double digit growth observed in FY2023. This may be worsened by the uncerta
The Phase 3 VIVID-1 trial evaluated the safety and efficacy of Omvoh in patients with or without prior biologic failure and was the basis for the positive opinion VIVID-1 was the first pivotal Crohn
EMA says Lilly's weight-loss drug does not need separate approval for sleep apnea
07:00am, Friday, 13'th Dec 2024
The European Medicines Agency said on Friday Eli Lilly's weight-loss drug does not need a separate approval for the treatment of a sleep disorder called obstructive sleep apnea (OSA).
Lilly's Mounjaro more popular than Wegovy in UK's private obesity drug market
01:04am, Friday, 13'th Dec 2024
Britons paying privately for obesity drugs are increasingly choosing Eli Lilly's Mounjaro over Novo Nordisk's Wegovy, online pharmacies say, in a sign the U.S. drugmaker is gaining ground on its Europ
Eli Lilly Reports Positive Data From Late-Stage Breast Cancer Study
09:41am, Thursday, 12'th Dec 2024
Data from a late-stage study shows that LLY's experimental oral drug benefited certain breast cancer patients when used as both a combination and monotherapy.
3 Stocks to Keep an Eye on After Dividend Hike Announcement
09:25am, Thursday, 12'th Dec 2024
Stocks like SYK, LLY and AES recently announced dividend hikes.
Eli Lilly Stock Could Have a Huge Growth Catalyst in Early 2025
07:45am, Thursday, 12'th Dec 2024
Eli Lilly (LLY -0.44%) may seem like an expensive stock to invest in right now. It's trading at close to 90 times its trailing earnings.
